Recent research has also found that the deletion of MAT2A mediated by CRISPR–Cas9 restricted the growth of hepatocellular carcinoma in mice by inhibiting T-cell exhaustion, which may be a potential strategy to enhance the ICI response of HCC (85). Here, MAT2A is linked to hepatocellular carcinoma.